Innovation

The new research aims to overcome barriers for using organs from someone who dies when their heart stops. Called DCD, or donation after circulatory death, it involves a controversial recovery technique or the use of expensive machines.

Novo Nordisk's Canadian patent for Ozempic expired after it didn't pay a $450 maintenance fee. With generic semaglutide on the horizon, was this a mistake that could cost the company billions?